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ABSTRACT 
Background: In patients with chronic heart failure (CHF), malnutrition might be related to 
right heart dysfunction and venous congestion, which predispose to bowel oedema and 
malabsorption, thereby leading to malnutrition. We explored the relation between congestion, 
malnutrition and mortality in a large cohort of ambulatory patients with CHF. 
Methods: We assessed malnutrition using the geriatric nutritional risk index (GNRI). 
Congestion was defined by echocardiography (raised right atrial pressure (RAP) = dilated 
inferior vena cava (IVC) >21 mm/ raised pulmonary artery systolic pressure (PAsP) = trans-
tricuspid gradient of ≥ 36mmHg/ right ventricular systolic dysfunction (RVSD) = TAPSE 
<17mm).  
Results: Of the 1058 patients enrolled, CHF was confirmed in 952 (69% males, median age 
75 (interquartile range (IQR):67-81) years, median NTproBNP 1141 (IQR: 465-2562) ng/L). 
39% had HF with reduced (HeFREF, LVEF<40%) and 61% had HF with normal (HeFNEF, 
LVEF≥40% and NTproBNP>125 ng/l) LVEF.  
Overall, 14% of patients were malnourished (GNRI ≤98). 35% had raised RAP, 23% had 
raised PAsP and 38% had RVSD.  Congestion was associated with malnutrition.  
During a median follow-up of 1683 days (IQR: 1096-2230 days), 461 (44%) patients died. 
Malnutrition was an independent predictor of mortality. Patients who were malnourished with 
both RVSD and increased RAP had much worse outcome  compared to non-malnourished 
patients without RVSD who had normal RAP.  
Conclusion: Malnutrition and congestion are modestly correlated and each is independently 
associated with increased mortality in patients with CHF. HF patients with both malnutrition 
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and congestion as evidenced by right heart dysfunction should be managed with additional 
vigilance. 
(250 words)  
Key words: Heart failure, malnutrition, congestion, echocardiography, right atrial pressure, 
pulmonary hypertension. 
 
Key Messages: 
What is already known about this subject? 
Malnutrition is common amongst patients with chronic heart failure (CHF) and is associated 
with worse prognosis, but its pathophysiology is not fully understood. Weight loss in CHF is 
associated with right heart dysfunction and intestinal congestion.  
 
What does this study add?  
We explored the relation between malnutrition and congestion (assessed clinically or by 
echocardiography) in a large cohort of well-characterised ambulatory patients with CHF and 
found that malnutrition and congestion are modestly associated with each other. The 
concomitant presence of malnutrition and congestion is strongly associated with high 
mortality. 
 
How might this impact on clinical practice? 
Patients with malnutrition and congestion are at high risk and should be managed with 
additional vigilance. Studies are needed to see if treating malnutrition specifically is helpful. 
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Introduction 
Malnutrition is common amongst patients with chronic heart failure (CHF). It has been 
implicated in the origin of cachexia, 1,2 and is associated with worse prognosis. 3,4,5  However, 
its pathophysiology is not fully understood.  
 
CHF is characterised by congestion and high systemic venous pressures. Previous work has 
suggested that cachexia in CHF is associated with both high right atrial pressure and tricuspid 
regurgitation.6,7,8 There is an association between RV dysfunction and intestinal and liver 
congestion9,10 and abnormal body composition11 in cachectic patients with CHF.  However, 
the relation between malnutrition, RV dysfunction and systemic venous congestion in 
patients with CHF has not been studied.  
 
We hypothesized that patients with CHF who have significant clinical congestion, high right 
heart pressures and right ventricular (RV) dysfunction might be at risk of developing 
congestive enteropathy, malabsorption and anorexia, thereby leading to clinical malnutrition 
and worse outcome. We studied the relation between congestion (assessed clinically and with 
echocardiography) and malnutrition, and the relation between these features and outcome in a 
large cohort of well-characterised ambulatory patients with CHF.  
 
 
Methods 
Study population 
From 2000, patients referred by either primary or secondary care physicians to a community 
CHF clinic serving a local population of about 500,000 people were enrolled in a longitudinal 
observational study of patients with CHF (The Hull LifeLab). Some patients had no prior 
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diagnosis of CHF and were treatment naive, therefore requiring initiation of guideline-
recommended therapy; many others had a pre-existing diagnosis of CHF and had already 
been initiated on treatment that might, however, require optimisation. We have previously 
reported the prevalence of moderate to severe malnutrition amongst patients with CHF is 7-
10%, depending upon the screening tool and definition used.12 In patients hospitalised for HF, 
up to 46% were malnourished.13 In the present paper, we focused on a subset of patients from 
the Hull LifeLab who were enrolled between 2008 and 2012 for whom we have detailed 
echocardiographic images, and studied the relation between congestion and malnutrition. 
 
All patients had a full medical history, physical examination, blood tests (including full blood 
count, urea and electrolytes and NTproBNP), an electrocardiogram and an echocardiogram. 
Weight was measured with the patients wearing their casual clothes but without shoes. Body 
mass index (BMI) was calculated using the formula: BMI = weight in kilograms / (height in 
meters) squared.   
 
CHF was defined as the presence of symptoms or signs of CHF and evidence of cardiac 
dysfunction, with either: left ventricular systolic dysfunction (left ventricular ejection fraction 
(LVEF) <40%; heart failure with reduced ejection fraction, HeFREF); or normal left 
ventricular systolic function (LVEF >40%) and raised N-terminal pro-B-type natriuretic 
peptide (NTproBNP) of >125ng/L (heart failure with normal ejection fraction, HeFNEF).14 
Patients whose LVEF was >40% and who had NTproBNP ≤125ng/L were considered not to 
have CHF. 
 
A congestion score was constructed, based on lung auscultation (normal, presence of basal, 
mid-zone or diffuse crackles), JVP (not visible, raised 1-4 cm, raised to earlobe), peripheral 
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oedema (none, ankles, below or above knees) and liver examination (not palpable, palpable) 
with one point attributed for each degree of severity and a total possible score of 9. Patients 
with a score of 3 or more were defined as severely congested.15 
 
Echocardiograms were performed by an experienced sonographer using a Vivid 5 or 7 
scanner (GE, Fairfield, Connecticut) with a 2.5-MHz phased-array transducer. Left 
ventricular (LV) systolic function was measured by calculating LVEF using Simpson’s 
method.  Right ventricular (RV) systolic function was measured by tricuspid annular plane 
systolic excursion (TAPSE). Patients with TAPSE <17mm were defined as having RV 
systolic dysfunction (RVSD).16  RV systolic pressure and right atrial pressure (RAP) were 
estimated from the maximal tricuspid regurgitation velocity (TR Vmax) and inferior vena 
cava (IVC) diameter respectively. Patients with IVC diameter of <21mm were considered to 
have normal RAP, whereas those with IVC diameter of ≥ 21 mm were considered to have an 
increased RAP.16 Patients with trans-tricuspid gradient of ≥ 36mmHg were considered to 
have raised pulmonary arterial systolic pressure (PAsP).16 Mitral and tricuspid regurgitation 
were assessed semi-quantitatively and expressed in 4 grades (absent, mild, moderate or 
severe).  
 
Ischaemic heart disease (IHD) was defined as any previous medical history of acute coronary 
syndrome (ACS), percutaneous coronary intervention or coronary artery bypass surgery, or a 
diagnosis of myocardial ischaemia based on invasive or non-invasive diagnostic tests. 
Cerebrovascular disease (CVD) was defined as any previous history of stroke or transient 
ischaemic attack (TIA). Peripheral vascular disease (PVD) was defined as a clinical history of 
the diagnosis.  
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Malnutrition screening 
Patients were screened for malnutrition using the geriatric nutritional risk index (GNRI),17  
which we have previously shown12 to have the greatest prognostic value compared to two 
other commonly used malnutrition screening tools: the controlling nutritional status 
(CONUT) score18 and the prognostic nutritional index (PNI).19   
 
The GNRI was calculated using the formula: 1.489 x serum albumin (g/L) + 41.7 x (body 
weight in kilograms / ideal body weight).16 Ideal body weight was calculated using the 
formula: 22 x square of height in meters.20 Patients with GNRI >98 have normal nutritional 
status, those with GNRI 92-98, 82-91, <82 have mild, moderate and severe malnutrition, 
respectively.  
 
End points and follow-up 
Patients were followed up until 1st May 2016. The primary endpoint was all-cause mortality. 
Our hospital is the only one in the region offering acute medical services. With previous 
consent from patients, we could access all their primary and secondary care records. Outcome 
was censored at the point of last medical contact in primary or secondary care. Data regarding 
hospitalisations and deaths were collected from the hospital’s electronic systems and were 
entered into a dedicated database, stored on a secure NHS server.  
 
Statistical analysis 
Continuous data are expressed as a median with interquartile range (IQR) (25th to 
75th centiles) and categorical data are expressed as N (%). Independent t tests and Mann-
Whitney U tests were used to compare two continuous variables for normally and non-
normally distributed data. The chi-squared test was used to compare proportions between 
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groups.  Pearson’s correlation or Spearman’s correlation coefficients were used to assess the 
relationships between two variables. Log-transformation was applied when the data were 
very skewed. Logistic regression analysis was used to estimate associations between other 
variables and malnutrition.  
 
The impact of variables on survival was investigated using the Cox proportional hazards 
model. Additionally, we created a base model for predicting mortality after adjusting for the 
following variables which are commonly available in clinical practice and are significantly 
associated with outcome: age, systolic blood pressure, New York Heart Association (NYHA) 
class, urea and NTproBNP. We added the malnutrition score (GNRI), markers of congestion 
(clinical and echocardiographic) and combinations of malnutrition and markers of congestion 
in turn to the base model and used C-index (the area under receiver operating characteristic 
(ROC) curves) and net reclassification index (NRI) to evaluate model discrimination in 
logistic regression analysis. The C-index is defined as the probability that predictions and 
outcomes are the same.  A C-index of 0.5 means that the relationship is no better than 
chance.  
 
All statistical analyses were performed using SPSS 22 (SPSS INc.,Chicago, IL, USA) and 
The Stata (14th Version, StataCorp, TX, USA) statistical computer package. A two-tailed P-
value of <0.05 was considered significant in all analyses. 
 
The study conformed to the principles outlined in the Declaration of Helsinki and was 
approved by relevant ethical bodies. All subjects gave their written informed consent for their 
data to be used for research. 
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Results 
Patient characteristics  
Baseline characteristics (clinical data and measures of congestion) of the overall cohort are 
shown in Table 1 (Appendix 1a, 1b). Baseline characteristics by GNRI (malnourished vs not 
malnourished), by RVSD and clinical congestion are shown in tables 2a-c. (Appendix 2) Of 
the patients with CHF, 10% had mild malnutrition and 4% had moderate to severe 
malnutrition. (Table 1and Appendix 2). Malnutrition was more common in patients with 
HeFREF than HeFNEF (17% vs 12%, p=0.01) (Appendix 1a). 
 
Prevalence of clinical signs of congestion  
Although a small proportion of patients without CHF had signs of congestion on clinical 
examination, patients with CHF were much more likely to have these signs (Table 1). 
Patients with HeFREF were as likely to have clinical signs of congestion as patients with 
HeFNEF (Appendix 1a). 
 
Prevalence of RV dysfunction and increased PAsP & RAP 
Compared to patients without CHF, those with CHF were more likely to have RVSD, raised 
PAsP and raised RAP. RVSD and increased RAP were more common in patients with 
HeFREF than in those with HeFNEF. (Appendix 1b)  
 
Clinical associations of malnutrition 
Compared to patients with normal nutritional status, patients with malnutrition were older, 
had lower BMI, worse renal function and HF symptoms, and higher NTproBNP levels (Table 
2a, Appendix 2). 
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Malnutrition and clinical signs of congestion 
Patients with CHF and malnutrition were more likely to have signs of congestion on clinical 
examination than those without malnutrition. Malnourished patients with HeFREF or 
HeFNEF were equally likely to have signs of congestion. (Appendix 2) Of the 4 clinical signs 
of congestion, peripheral oedema and raised JVP were the two commonest.  
 
Malnutrition and echocardiographic findings 
Patients with malnutrition were more likely to have RVSD and increased PAsP and RAP 
compared to those with normal nutrition. (Table 2a) The simultaneous presence of RVSD and 
increased RAP was much more common in malnourished patients than in non-malnourished 
patients (33% vs 17%, p<0.001). The prevalence of LV systolic dysfunction and LA dilation 
was not related to malnutrition (Table 2a). Box plot figures comparing the key 
echocardiographic measures in malnourished versus non-malnourished patients with HeFREF 
versus HeFNEF were shown in Appendix 3a-e.  
 
Correlations between malnutrition and echocardiographic findings 
Worsening malnutrition correlated with increasing NTproBNP levels, increasing age and 
worsening right ventricular dysfunction by ultrasound: decreasing TAPSE, increasing RAP 
and PAsP (Appendix 4). Malnutrition was more strongly linked to elevated right-sided 
pressures than to either right or left ventricular dysfunction (Appendix 4).  
 
If we used an NT-proBNP cut-off of >400 ng/l to diagnose HeFNEF, in accordance to NICE 
guidelines21, the prevalence of congestion and malnutrition would have been slightly higher 
amongst patients with HeFNEF (congestion: from 15% to 18%; RVSD: from 30% to 34%, 
malnutrition from 12% to 15%). However, the change of cut-off does not alter the modest 
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relationship between congestion, RVSD and malnutrition (worsening malnutrition correlated 
with decreasing TAPSE (correlation coefficient from 0.21 to 0.17 (both p <0.001) and 
increasing congestion score (correlation coefficient remains the same: 0.05, p = 0.15 and 
p=0.16 respectively). 
 
Logistic regression analysis of clinical and echocardiographic variables associated with 
malnutrition is shown in Table 3. NTproBNP (OR 5.7, 95% CI 3.2-10.1, p<0.001) had the 
strongest association with malnutrition, followed by trans-tricuspid gradient (OR 1.11, 95% 
CI 1.0-1.2), p=0.03). (Table 3)  
 
 
Malnutrition, echocardiographic findings and hospitalisation in the year before 
recruitment 
539 (57%) of patients were admitted to hospital in the year before recruitment, of which 181 
(34%) were HF admissions.  Patients with previous hospitalisations for HF were more likely 
to be malnourished and have raised RAP / PAsP or RVSD compared to patients with 
previous cardiovascular but non-HF hospitalisations or no hospitalisations. (Appendix 5)  
 
Malnutrition, RVSD and mortality 
During a median follow-up of 1683 days (interquartile range: 1096-2230 days), 461 (44%) 
patients died.  
 
Univariable and multivariable predictors of mortality for the overall population and for the 
different HF phenotypes are shown in table 4 and Appendix 6a-b. In univariable analysis, the 
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presence of malnutrition, signs of congestion, increasing PASP, RAP and left atrial volume 
index (LAVI) and decreasing TAPSE and LVEF were associated with worse outcome.  
In a multivariable model including all the patients, malnutrition was independently associated 
with an increased risk of all-cause mortality. Of the echocardiographic variables, only 
increasing RAP and LAVI were significant predictors of mortality.  (Table 4, Appendix 7)   
 
The Kaplan-Meier curves for the relationship between malnutrition, RV dysfunction, 
increased RAP and outcome is shown in figure 1. Compared to patients who were not 
malnourished with normal RV function and RAP, those with malnutrition and normal RV 
function and RAP had a 2 fold increase in the risk of death for any cause. Those who were 
malnourished with RV dysfunction and raised RAP had the worst outcome.(Figure 1)  
 
A base model (including age, systolic blood pressure, NYHA class, urea and NTproBNP) for 
predicting mortality achieved a C-index = 0.79.  (Table 5) Moderate to severe malnutrition by 
GNRI and markers of congestion (both clinical and echocardiographic), when added 
individually, did not improve performance of the base model. The net reclassification index 
(NRI) produced similar results. Addition of moderate to severe malnutrition by GNRI and 
clinical congestion (congestion score ≥3) in combination and addition of moderate to severe 
malnutrition by GNRI and IVC diameter in combination improved performance of base 
model (C = 0.80 and 0.81 respectively, p =0.02 for both).  
 
Discussion  
Ours is the one of the few studies 9,10, 22,23 to explore the relation between malnutrition and 
congestion in patients with CHF.  Our study comprehensively investigated the associations 
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between malnutrition, right heart dysfunction and venous congestion assessed clinically, 
biochemically and by echocardiography. 
 
We hypothesised that malnutrition might be caused by congestion, but only found a modest 
relation between malnutrition and measures of congestion. Although ours is a study of 
associations of malnutrition, and thus few conclusions can be drawn about causation, the 
weakness of the correlation between the two suggests that one does not directly cause the 
other.  Congestion and malnutrition were independent predictors of mortality, again 
suggesting that they are measures of different aspects of the heart failure syndrome and may 
not be causally related. 
 
One explanation for our findings might be that it is historical congestion that causes 
malnutrition and that the malnutrition we measured at the time of the assessment would not 
be related to any congestion present at the time. We found that patients with previous 
admissions for HF were more likely to be malnourished or have raised RAP, PAsP or RVSD 
compared to patients with previous cardiovascular but non-HF hospitalisations or no 
hospitalisation, which might imply a closer link between malnutrition and previous 
congestion.  
 
Our findings are similar to those from Valentova et al, who studied the relationship between 
congestion and cardiac cachexia in 169 outpatients with heart failure due to left ventricular 
systolic dysfunction.9 They found that cachexia was more common in patients with reduced 
RV function and elevated RAP than in patients with either reduced RV function but normal 
RAP or preserved RV function (67 vs. 15 vs. 7%). They also found that cachexia was 
associated with thicker bowel wall (odds ratio (OR) 1.3; 95% CI: 1.1–1.6; P = 0.002).  
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Previous work has mainly focused on identifying mechanistically plausible explanations for 
the association between cachexia/ malnutrition and congestion/cardiac dysfunction in patients 
with CHF. Congestion and cardiac dysfunction have been implicated as a cause of 
malnutrition. Systemic venous congestion in the hepatic and splanchnic beds cause intestinal 
congestion and dysmotility, anorexia, malabsorption and increased intestinal permeability 
with protein loss and endotoxin translocation.24 Neuro-hormonal activation exacerbates renal 
dysfunction, leading to more salt and water retention, contributing to bowel congestion and 
development of malnutrition.8  Chronic intestinal congestion might cause persistent 
lipopolysaccharide translocation which might induce systemic release of pro-inflammatory 
cytokines and worsen the underlying intestinal congestion.8 In addition, RV dysfunction and 
pulmonary hypertension cause the release of natriuretic peptides,25 which stimulates lipolysis 
of adipose tissue26 and indirectly stimulate secretion of adiponectin which promotes glucose 
and fatty acid utilisation,27 resulting in weight loss and increased mortality. 
 
Malnutrition might itself aggravate underlying left and right heart dysfunction, leading to a 
vicious spiral of deterioration. Metabolites and cytokines released secondary to 
malnourishment state might adversely affect cardiac performance. Cytokines such as TNF-α, 
raised in patients with cachexia, have potent negative inotropic effects and might 
subsequently impair RV and LV systolic function.28  
 
Although we found that malnutrition is associated with congestion, the association is modest, 
suggesting that they are two distinct entities. Other factors such as advanced age and severity 
of CHF might also have important roles to play in the pathogenesis of malnutrition. Patients 
with CHF often suffer from multiple comorbidities, such as osteoarthritis, airways disease, 
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renal dysfunction, cognitive impairment, anxiety and depression, which might interact with 
and/or modify the course of CHF and have negative impact on medication adherence, self-
care ability and food intake.29 Lack of social support and financial constraints negatively 
impact on activities of daily living, such as shopping and preparing meals, hence 
predisposing to malnutrition.  
 
Limitations 
This is a single-centre study conducted in the UK; external validation of our results from 
other countries with different healthcare and social systems is needed. Secondly, we have 
only studied one of the large number of tools available to screen for malnutrition. Thirdly, 
this is an observational study, and thus causality cannot be addressed.  
 
Additionally, up-titration of anti-HF medications during follow-up for patients with HeFREF 
might have led to an improved congestive and nutritional status, and perhaps outcome, in 
some.  
 
Furthermore, this study is an explorative analysis using a comprehensive prospective data 
collection undertaken as part of the Hull LifeLab database between 2008 and 2012. The 
analysis plan was decided post-hoc, and results might have changed overtime, particularly as 
newer treatments have become available.  
 
The GNRI is derived from serum albumin and the ratio of body weight to ideal body weight. 
Although it is questionable whether an ideal BMI of 22 kg/m2 as used in our formula to 
calculate ideal body weight applies to a UK population, as it might underestimate prevalence 
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of malnutrition in our population, a recent report from UK Biobank enrolling more than 
200,000 UK residents without cardiovascular risk factors supports these findings.30 
 
Lastly, we have included patients with HeFNEF, for which there is no universally agreed 
diagnostic definition and some might not accept our definition based only on the evidence of 
signs or symptoms supported by a natriuretic peptide level above the diagnostic level 
suggested by current ESC-HF guidelines (125 ng/L).  
  
 
Conclusion 
Malnutrition and congestion are both common but are only modestly associated with each 
other in patients with chronic heart failure. The concomitant presence of malnutrition and 
congestion is strongly associated with a high mortality in patients with CHF; these patients 
should thus be managed with additional vigilance.  
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Appendix 1a: Baseline characteristics (clinical data) for all patients. 
Appendix 1b: Baseline characteristics (clinical and echocardiographic measures of 
congestion) of all patients 
Appendix 2: Baseline characteristics of HF patients (HeFREF vs HeFNEF) by GNRI 
categories 
Appendix 3a-e: Box plot figures comparing echocardiographic markers in malnourished 
versus non-malnourished patients with HeFREF versus HeFNEF. 
Appendix 4: Correlations between clinical and echocardiographic variables and malnutrition 
scores in patients with HF.  
Appendix 5: The relationship between hospitalisation in the year before recruitment and 
development of malnutrition and raised RAP/ PAsP or RVSD during assessment. (Expressed 
as: number of patients (%)). 
Appendix 6a: Univariable and multivariable analyses of factors predicting outcomes in heart 
failure patients with reduced ejection fraction 
Appendix 6b: Univariable and multivariable analyses of factors predicting outcomes in heart 
failure patients with preserved ejection fraction 
Appendix 7: Forest plot on multivariable analysis of factors predicting outcomes in patients 
with CHF (overall population)  
 
 
Tables: 
Table 1: Baseline characteristics of all patients. 
Table 2a: Baseline characteristics of HF patients (malnourished vs not malnourished) 
Table 2b: Baseline characteristics of HF patients (RVSD vs no RVSD) 
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Table 2c: Baseline characteristics of HF patients (clinical congestion vs no clinical 
congestion) 
Table 3: Logistic regression analysis of clinical and echocardiographic variables associated 
with malnutrition in HF subjects (Backward selection).  
Table 4: Univariable and multivariable analyses of factors predicting outcomes in patients 
with heart failure.  
Table 5: Effect of addition of clinical congestion and echocardiographic markers of right 
cardiac dysfunction to base model in predicting mortality. 
 
Figure: 
Figure 1: Kaplan meier curve showing the relation amongst malnutrition, right ventricular 
systolic dysfunction and increased right atrial pressure and all-cause mortality. 
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Table 1. Baseline characteristics of the entire cohort. 
 
 
HF= heart failure,  BMI= body mass index, BP= blood pressure, HR= heart rate, NYHA = New York Heart Association Class, IHD = ischaemic heart disease, CVA = 
cerebrovascular disease,  COPD= chronic obstructive pulmonary disease, Hb = Haemoglobin, Na+ = sodium, NTproBNP = N-terminal Pro Brain Natriuretic 
Peptide, MRA = Mineralocorticoids receptor antagonists, ACEi = Angiotensin-converting enzyme inhibitor, ARB = Angiotensin receptor blocker, BB= 
betablocker, GNRI = Geriatric nutritional risk index. 
 
 No HF 
 (N=102) 
HF 
 (N=952) 
Missing P-value 
Demographics 
Age (years) 64 (50-70) 75 (67-81) 0 <0.001 
Sex (male), n (%) 71 (70) 655 (69) 0 0.87 
Weight (kg) 88 (76-100) 80 (68-95) 0 0.002 
BMI (kg/m2) 30 (27-34) 28 (25-32) 0 0.002 
BP systolic (mmHg) 133 (118-151) 126 (111-144) 0 0.01 
HR (bpm) 71 (63-80) 70 (61-78) 0 0.27 
Sinus rhythm, n (%) 102 (100) 606 (64) 0 <0.001 
NYHA III, n (%) 11 (11) 317 (33) 0 <0.001 
Comorbidities 
IHD, n (%) 33 (32) 579 (61) 0 <0.001 
Diabetes, n (%) 28 (28) 285 (30) 0 0.60 
Hypertension, n(%) 57 (56) 498 (52) 0 0.49 
CVA, n (%) 5 (5) 90 (10) 0 0.13 
COPD, n (%) 11 (11) 109 (11) 0 0.84 
Blood tests 
Hb (g/dL) 14.1 (13.2-15.4) 13.3 (12.0-14.3) 0 <0.001 
Urea (mmol/L) 4.9 (3.9-6.1) 7.3 (5.5-10.2) 0 <0.001 
Creatinine (umol/L) 84 (70-98) 103 (84-134) 0 <0.001 
Na+ (mmol/L) 139 (138-140) 138 (136-140) 1 0.12 
Albumin (g/L) 41 (38-42) 38 (36-40) 0 <0.001 
NTproBNP (ng/L) 59 (33-93) 1141 (465-2562) 1 <0.001 
Treatment 
Loop diuretic, n (%) 36 (35) 661 (69) 0 <0.001 
MRA, n (%) 21 (21) 344 (36) 0 0.002 
ACEi or ARB, n (%) 67 (66) 805 (85) 0 <0.001 
BB, n (%) 44 (43) 736 (77) 0 <0.001 
Malnutrition 
GNRI 
Normal (>98) 
Mild malnutrition (92-98) 
Moderate malnutrition (82-91) 
Severe malnutrition (<82) 
 
97 (95) 
5 (5) 
0 
0 
 
820 (86)  
98 (10) 
30 (3) 
4 (1) 
0 
 
 
 
 
0.07 
 
 
 
 
Table 2a: Baseline characteristics of HF patients (malnourished vs not malnourished) 
 
 Malnutrition Missing P-value 
Yes 
 (N=132) 
No 
 (N=820) 
Demographics 
Age (years) 80 (74-84) 74 (66-80) 0 <0.001 
Sex (male), n (%) 83 (63) 572 (70) 0 0.11 
Weight (kg) 59 (53-68) 84 (73-97) 0 <0.001 
BMI (kg/m2) 22 (20-24) 29 (26-33) 0 <0.001 
BP systolic (mmHg) 118 (103-138) 129 (112-146) 0 <0.001 
HR (bpm) 70 (60-78) 70 (61-79) 0 0.73 
Sinus rhythm, n (%) 89 (67) 517 (63) 0 0.33 
NYHA III, n (%) 60 (46) 257 (31) 0 0.001 
Comorbidities 
IHD, n (%) 84 (64) 495 (60) 0 0.48 
Diabetes, n (%) 23 (17) 262 (32) 0 0.001 
Hypertension, n(%) 55 (42) 443 (54) 0 0.008 
CVA, n (%) 14 (11) 76 (9) 0 0.63 
COPD, n (%) 21 (16) 88 (11) 0 0.08 
Blood tests 
Hb (g/dL) 12.4 (10.9-13.7) 13.3 (12.2-14.5) 0 <0.001 
Urea (mmol/L) 9.0 (6.4-12.6) 7.2 (5.4-9.9) 0 <0.001 
Creatinine (umol/L) 114 (86-145) 102 (84 -132) 0 <0.001 
Na+ (mmol/L) 137 (135-140) 138 (137-140) 1 <0.001 
Albumin (g/L) 35 (32-37) 39 (37-41) 0 <0.001 
NTproBNP (ng/L) 2884 (1444-4973) 1015 (406-2089) 1 <0.001 
Treatment 
Loop diuretic, n (%) 98 (74) 563 (69) 0 0.20 
MRA, n (%) 50 (38) 294 (36) 0 0.65 
ACEi or ARB, n (%) 99 (75) 706 (86) 0 0.001 
BB, n (%) 102 (77) 634 (77) 0 0.99 
Clinical congestion 
Lung crackles (>1) 28 (21) 92 (11) 0 0.001 
Raised JVP (>1) 31 (24) 94 (12) 0 <0.001 
Peripheral oedema (>1) 40 (30) 162 (20) 0 0.006 
Palpable liver 17 (13) 34 (4) 0 <0.001 
Congested (congestion score >3) 36 (27) 105 (13) 0 <0.001 
Echocardiography 
Increased RAP (IVC ≥21mm) 64 (50) 254 (32) 33 <0.001 
RVSD (TAPSE<17mm) 65 (49) 295 (36) 0 0.004 
Increased PAsP 53 (41) 155 (20) 35 <0.001 
  
HF= heart failure,  BMI= body mass index, BP= blood pressure, HR= heart rate, NYHA = New York Heart Association Class, IHD = 
ischaemic heart disease, CVA = cerebrovascular disease,  COPD= chronic obstructive pulmonary disease, Hb = Haemoglobin, Na+ = 
sodium, NTproBNP = N-terminal Pro Brain Natriuretic Peptide, MRA = Mineralocorticoids receptor antagonists, ACEi = Angiotensin-
converting enzyme inhibitor, ARB = Angiotensin receptor blocker, BB= betablocker, GNRI = Geriatric nutritional risk index, LVEF= left 
ventricular ejection fraction, LAVI= left atrial volume index, TAPSE= tricuspid annular plane systolic excursion, IVC= inferior vena cava, 
RVSD= right ventricular systolic dysfunction, PAsP= pulmonary artery systolic pressure, RAP= right atrial pressure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Trans-tricuspid gradient ≥36mmHg) 
LA dilatation (LAVI >34 mL/m2) 94 (71) 535 (65) 0 0.18 
LVSD (LVEF <40%) 61 (46) 308 (38) 0 0.06 
Mitral regurgitation (mod to sev) 32 (24) 113 (14) 1 0.002 
Tricuspid regurgitation (mod to sev) 28 (21) 57 (7) 0 <0.001 
 Table 2b: Baseline characteristics of HF patients (RVSD vs no RVSD) 
 
 RVSD Missing P-value 
Yes 
 (N=360) 
No  
 (N=592) 
Demographics 
Age (years) 76 (70-82) 74 (66-81) 0 0.006 
Sex (male), n (%) 262 (73) 393 (66) 0 0.04 
Weight (kg) 77 (66-89) 82 (70-97) 0 <0.001 
BMI (kg/m2) 27 (24-31) 29 (25-33) 0 <0.001 
BP systolic (mmHg) 121 (105-139) 130 (115-148) 0 <0.001 
HR (bpm) 121 (105-139) 68 (60-76) 0 <0.001 
Sinus rhythm, n (%) 177 (49) 429 (73) 0 <0.001 
NYHA III, n (%) 156 (43) 161 (27) 0 <0.001 
Comorbidities 
IHD, n (%) 241 (67) 338 (57) 0 0.003 
Diabetes, n (%) 106 (29) 179 (30) 0 0.80 
Hypertension, n(%) 163 (45) 335 (57) 0 0.001 
CVA, n (%) 37 (10) 53 (9) 0 0.50 
COPD, n (%) 44 (12) 65 (11) 0 0.56 
Blood tests 
Hb (g/dL) 13.2 (12.0-14.2) 13.3 (12.1-14.4) 0 0.15 
Urea (mmol/L) 8.3 (6.1-11.3) 7.0 (5.3-9.7) 0 <0.001 
Creatinine (umol/L) 109 (88-141) 100 (82-131) 0 0.27 
Na+ (mmol/L) 138 (136-140) 139 (137-140) 1 0.05 
Albumin (g/L) 38 (36-40) 38 (36-40) 0 0.07 
NTproBNP (ng/L) 1926 (882-3907) 800 (364-1784) 1 <0.001 
Treatment 
Loop diuretic, n (%) 285 (79) 376 (64) 0 <0.001 
MRA, n (%) 162 (45) 182 (31) 0 <0.001 
ACEi or ARB, n (%) 302 (84) 503 (85) 0 0.66 
BB, n (%) 458 (77) 278 (77) 0 0.96 
Clinical congestion 
Lung crackles (>1) 58 (16) 62 (11) 0 0.01 
Raised JVP (>1) 79 (22) 46 (8) 0 <0.001 
Peripheral oedema (>1) 89 (25) 113 (19) 0 0.04 
Palpable liver 33 (9) 18 (3) 0 <0.001 
Congested (congestion score >3) 81 (23) 60 (10) 0 <0.001 
Echocardiography 
Increased RAP (IVC ≥21mm) 179 (51) 139 (24) 33 <0.001 
Increased PAsP 126 (36) 82 (14) 35 <0.001 
 HF= heart failure,  BMI= body mass index, BP= blood pressure, HR= heart rate, NYHA = New York Heart Association Class, IHD = 
ischaemic heart disease, CVA = cerebrovascular disease,  COPD= chronic obstructive pulmonary disease, Hb = Haemoglobin, Na+ = 
sodium, NTproBNP = N-terminal Pro Brain Natriuretic Peptide, MRA = Mineralocorticoids receptor antagonists, ACEi = Angiotensin-
converting enzyme inhibitor, ARB = Angiotensin receptor blocker, BB= betablocker, GNRI = Geriatric nutritional risk index, LVEF= left 
ventricular ejection fraction, LAVI= left atrial volume index, TAPSE= tricuspid annular plane systolic excursion, IVC= inferior vena cava, 
RVSD= right ventricular systolic dysfunction, PAsP= pulmonary artery systolic pressure, RAP= right atrial pressure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Trans-tricuspid gradient ≥36mmHg) 
LA dilatation (LAVI >34 mL/m2) 272 (76) 357 (60) 0 <0.001 
LVSD (LVEF <40%) 184 (51) 185 (31) 0 <0.001 
Mitral regurgitation (mod to sev) 86 (24) 59 (10) 1 <0.001 
Tricuspid regurgitation (mod to sev) 63 (18) 22 (4) 0 <0.001 
Malnutrition 
GNRI 
Normal (>98) 
Mild malnutrition (92-98) 
Moderate malnutrition (82-91) 
Severe malnutrition (<82) 
 
295 (82) 
51 (14) 
12 (3) 
2 (1) 
 
525 (89) 
47 (8) 
18 (3) 
2 (0) 
0 0.02 
Table 2c: Baseline characteristics of HF patients (clinical congestion vs no clinical 
congestion) 
 
 
 
 Clinical Congestion Missing P-value 
Yes 
 (N=141) 
No  
 (N=811) 
Demographics 
Age (years) 79 (74-84) 74 (66-80) 0 <0.001 
Sex (male), n (%) 96 (68) 559 (69) 0 0.84 
Weight (kg) 77 (67-95) 80 (69-95) 0 0.51 
BMI (kg/m2) 28 (25-32) 28 (25-33) 0 0.66 
BP systolic (mmHg) 124 (108-142) 127 (111-144) 0 0.15 
HR (bpm) 72 (63-86) 70 (60-78) 0 <0.001 
Sinus rhythm, n (%) 63 (45) 543 (67) 0 <0.001 
NYHA III, n (%) 95 (67) 222 (27) 0 <0.001 
Comorbidities 
IHD, n (%) 83 (59) 496 (61) 0 0.61 
Diabetes, n (%) 45 (32) 240 (30) 0 0.58 
Hypertension, n(%) 72 (51) 426 (53) 0 0.75 
CVA, n (%) 74 (9) 16 (11) 0 0.41 
COPD, n (%) 16 (11) 93 (12) 0 0.97 
Blood tests 
Hb (g/dL) 12.4 (11.1-13.8) 13.3 (12.2-14.4) 0 <0.001 
Urea (mmol/L) 9.7 (6.8-13.2) 7.1 (5.4-9.8) 0 <0.001 
Creatinine (umol/L) 118 (91-152) 101 (83-131) 0 0.05 
Na+ (mmol/L) 138 (135-140) 138 (137-140) 1 0.19 
Albumin (g/L) 36 (34-39) 38 (37-40) 0 <0.001 
NTproBNP (ng/L) 2810 (1357-4787) 1014 (409-2064) 1 <0.001 
Treatment 
Loop diuretic, n (%) 125 (89) 536 (66) 0 <0.001 
MRA, n (%) 58 (41) 286 (35) 0 0.18 
ACEi or ARB, n (%) 109 (77) 696 (86) 0 0.01 
BB, n (%) 104 (74) 632 (78) 0 0.28 
Echocardiography 
Increased RAP (IVC ≥21mm) 93 (67) 225 (29) 33 <0.001 
RVSD (TAPSE<17mm) 81 (57) 279 (34) 0 <0.001 
Increased PAsP 
(Trans-tricuspid gradient ≥36mmHg) 
71 (53) 137 (18) 35 <0.001 
LA dilatation (LAVI >34 mL/m2) 120 (85) 509 (63) 0 <0.001 
LVSD (LVEF <40%) 51 (36) 318 (39) 0 0.49 
  
 
HF= heart failure,  BMI= body mass index, BP= blood pressure, HR= heart rate, NYHA = New York Heart Association Class, IHD = 
ischaemic heart disease, CVA = cerebrovascular disease,  COPD= chronic obstructive pulmonary disease, Hb = Haemoglobin, Na+ = 
sodium, NTproBNP = N-terminal Pro Brain Natriuretic Peptide, MRA = Mineralocorticoids receptor antagonists, ACEi = Angiotensin-
converting enzyme inhibitor, ARB = Angiotensin receptor blocker, BB= betablocker, GNRI = Geriatric nutritional risk index, LVEF= left 
ventricular ejection fraction, LAVI= left atrial volume index, TAPSE= tricuspid annular plane systolic excursion, IVC= inferior vena cava, 
RVSD= right ventricular systolic dysfunction, PAsP= pulmonary artery systolic pressure, RAP= right atrial pressure. 
 
 
Mitral regurgitation (mod to sev) 33 (24) 112 (14) 1 0.003 
Tricuspid regurgitation (mod to sev) 41 (29) 44 (5) 0 <0.001 
Malnutrition 
GNRI 
Normal (>98) 
Mild malnutrition (92-98) 
Moderate malnutrition (82-91) 
Severe malnutrition (<82) 
 
105 (75) 
24 (17) 
10 (7) 
2 (2) 
 
715 (88) 
74 (9) 
20 (3) 
2 (0) 
0 <0.001 
Table 3: Logistic regression analysis of clinical and echocardiographic variables 
associated with malnutrition in all HF subjects. (Backward selection) 
 
HF= heart failure, NYHA = New York Heart Association Class , NTproBNP= N-terminal Pro Brain Natriuretic 
Peptide , LVEF=  left ventricular ejection fraction, LAVI= left atrial volume index,  IVC= inferior vena cava, TAPSE= tricuspid 
annular plane systolic excursion. 
 
  Univariable  Multivariable 
OR 
 (95% CI) 
Wald 
X2 
P OR 
 (95% CI) 
Wald 
X2 
P 
Age 1.06 
(1.04-1.08) 
27.4 <0.001 1.03 
(1.01-1.06) 
7.9 0.005 
Log NTproBNP 6.15 
(4.04-9.36) 
71.8 <0.001 5.68 
(3.20-10.06) 
35.4 <0.001 
LVEF (per 5% increase) 0.93 
(0.86-0.99) 
4.8 0.03    
LAVI (per 10 mL/m2 increase) 1.10  
(1.02-1.19) 
5.8 0.02    
TAPSE (per 5mm increase) 0.69  
(0.56-0.85) 
12.4 
 
<0.001    
Trans-tricuspid gradient  
(per 5 mmHg increase) 
1.24  
(1.15-1.33) 
32.5 <0.001 1.11  
(1.01-1.22) 
4.7 0.03 
IVC  diameter 
(per 5 mm increase) 
1.42  
(1.18-1.71) 
14.0 <0.001    
Table 4: Univariable and multivariable analysis of factors predicting outcomes in patients with HF (overall population) 
 
 
Worse outcome per unitary increase 
Overall HF population  (N=952) 
Univariate Multivariate 
HR(95%CI) Wald Χ2 P-value HR(95%CI) Wald Χ2 P-value 
Demographics 
Age (years) 
Sex (male vs female) 
BP systolic (per 10 mmHg) 
HR (bpm) 
Sinus rhythm (Y vs N) 
 
1.05 (1.04-1.06) 
1.20 (0.98-1.47) 
0.92 (0.89-0.96) 
1.01 (1.00-1.01) 
0.78 (0.65-0.94) 
 
97.2 
3.0 
16.3 
4.1 
6.6 
 
<0.001 
0.08 
<0.001 
0.04 
0.01 
 
1.04 (1.03-1.06) 
1.46 (1.14-1.85) 
0.94 (0.90-0.98) 
 
0.71 (0.55-0.91) 
 
43.5 
9.3 
9.1 
 
7.5 
 
<0.001 
0.002 
0.003 
 
0.006 
Clinical examination 
Congested (Y vs N) 
NYHA (III/IV vs I/II) 
 
2.77 (2.23-3.43) 
2.65 (2.20-3.18) 
 
85.5 
108.3 
 
<0.001 
<0.001 
 
 
1.61 (1.31-1.99) 
 
 
20.1 
 
 
<0.001 
Comorbidities 
IHD (Y vs N) 
CVA (Y vs N) 
 
1.23 (1.01-1.49) 
1.76 (1.35-2.30) 
 
4.3 
17.3 
 
0.04 
<0.001 
 
 
1.41 (1.06-1.89) 
 
 
5.5 
 
 
0.02 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
HF= heart failure, BP= blood pressure, HR= heart rate, NYHA = New York Heart Association Class, IHD = ischaemic heart disease, CVA = cerebrovascular disease,  Hb = Haemoglobin, Na+ = sodium, NTproBNP = 
N-terminal Pro Brain Natriuretic Peptide, LVEF=  left ventricular ejection fraction, LVEDD= left ventricular end diastolic diameter, TAPSE= tricuspid annular plane systolic excursion,  LAVI= left atrial volume 
index, TR Vmax= maximal tricuspid regurgitation velocity, Mod/sev= moderate or severe, GNRI = Geriatric nutritional risk index, Y= yes, N=No. 
For continuous variables, HR relate to the hazard associated per unitary increase in the variable except for systolic BP, where HR relates to the hazard associated per10 unitary increase.  For categorical variables (*), 
HR quoted compares groups specified in brackets. 
 
Lung crepitations, Raised JVP, Peripheral oedema, Palpable liver are excluded as these are included in congested. 
Weight, BMI, BSA are excluded as these are included in GNRI. 
Blood test 
Hb (g/dL) 
Urea (mmol/L) 
Na+ (mmol/L) 
Log NTproBNP (ng/L) 
 
0.78 (0.74-0.82) 
1.08 (1.06-1.09) 
0.93 (0.90-0.96) 
3.48 (2.89-4.18) 
 
86.6 
91.3 
27.5 
175.9 
 
<0.001 
<0.001 
<0.001 
<0.001 
 
 
 
0.96 (0.93-0.99) 
1.49 (1.13-1.96) 
 
 
 
9.2 
8.0 
 
 
 
0.002 
0.005 
Echocardiography 
LVEF (%) 
LVEDD (cm) 
TAPSE (mm) 
LAVI (mL/m2) 
Trans-tricuspid gradient (mmHg) 
IVC  diameter (mm) 
 
0.99 (0.99-1.00) 
1.01 (1.00-1.02) 
0.93 (0.91-0.95) 
1.02 (1.01-1.02) 
1.03 (1.03-1.04) 
1.09 (1.08-1.11) 
 
4.6 
2.7 
48.4 
87.8 
84.0 
98.6 
 
0.03 
0.10 
<0.001 
<0.001 
<0.001 
<0.001 
 
 
 
 
1.01 (1.00-1.01) 
 
1.04 (1.01-1.06) 
 
 
 
 
5.8 
 
5.6 
 
 
 
 
0.02 
 
0.02 
Malnutrition 
GNRI (mod/sev) (Y vs N) 
 
1.75 (1.14-2.68) 
 
6.5 
 
0.01 
 
2.32 (1.49-3.62) 
 
13.8 
 
<0.001 
WCC, lymphocyte, albumin, cholesterol are excluded as these are included in PNI, CONUT. 
Creatinine is excluded as urea is considered as a marker of renal function. 
LA diameter and volume are excluded as LAVI is considered as a marker of LA dimensions. 
GLS and e/e’ are excluded due to large amount of missing values. 
 
 
Table 5: Effect of addition of clinical congestion and echocardiographic markers of 
right cardiac dysfunction to base model in predicting mortality. 
 
** clinical congestion (congestion score ≥3 vs congestion score <3), ***GNRI (moderate to severe 
malnutrition vs mild or no malnutrition) 
Model c-statistics  
(Compared to  
model 1, p-value) 
c-statistics 
 
(compared to model 
6) 
 
cNRI 
(standard 
error) 
(compared to 
model 1, p-
value) 
1. Base model* 0.789 (0.754-
0.823) 
- - 
2. Base + clinical congestion** 0.796 (0.762-
0.830) 
P=0.10 
- 0.03 (0.08) 
P=0.69 
3. Base + TAPSE 0.789 (0.75-0.82) 
P=0.83 
- 0.013 (0.08) 
P=0.87 
4. Base + IVC 0.796 (0.76-0.83) 
P=0.18 
- 0.14(0.08) 
P=0.07 
5. Base + Trans-tricuspid 
gradient 
0.791 (0.756-
0.826) 
P=0.60 
- -0.0003 
(0.08) 
P=1.0 
6. Base + GNRI***  0.797 (0.762-
0.831) 
P=0.12 
0.797 (0.762-0.831) 
 
0.08(0.08) 
P=0.29 
7. Base + GNRI*** + clinical 
congestion 
0.80 (0.77-0.84) 
P=0.018 
0.803 (0.770-0.837) 
P=0.08 
- 
8. Base + GNRI*** + IVC 0.807 (0.77-0.84) 
P=0.017 
0.807(0.772-0.832) 
P=0.075 
- 
9. Base + GNRI*** + TAPSE 0.797(0.76-0.83) 
P=0.11 
0.797 (0.763-0.831) 
P=0.78 
- 
10. Base + GNRI***+ Trans-
tricuspid gradient 
0.798(0.76-0.83) 
P=0.12 
0.798 (0.763-0.833) 
P=0.78 
- 
TAPSE= tricuspid annular plane systolic excursion, IVC=inferior vena cava diameter, NRI= net reclassification index 
 

